Skip to main content
. Author manuscript; available in PMC: 2014 Jul 28.
Published in final edited form as: Arch Gen Psychiatry. 2009 Jun;66(6):583–590. doi: 10.1001/archgenpsychiatry.2009.30

Figure 2.

Figure 2

Percentage of children with a rating of much improved or very much improved on the Clinical Global Impressions, Improvement subscale during the 12-week trial. All children assigned to citalopram hydrobromide (n=73) and to placebo (n=76) are included. Week 2 is the first opportunity to assess change from baseline. Using the generalized estimating equation method, there was no statistical difference between groups over time.